Short answer
HAEMONETICS CORP (HAE) filed an 8-K current report with the SEC on March 3, 2026 reporting Item 7.01 (Regulation FD Disclosure). Reg FD disclosure signed by CFO James C. D'Arecca on March 3, 2026: substantive disclosed content contained in referenced exhibit.
HAEMONETICS CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Reg FD disclosure signed by CFO James C. D'Arecca on March 3, 2026: substantive disclosed content contained in referenced exhibit
- No financial figures or operational details present in the filing text itself; investor impact depends on exhibit content
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other HAEMONETICS CORP 8-K filings
Get the next HAE 8-K as it lands
Follow HAE for push alerts, or ask the research agent what this filing means.